Jorma Mattila

1.5k total citations
33 papers, 1.2k citations indexed

About

Jorma Mattila is a scholar working on Epidemiology, Oncology and Surgery. According to data from OpenAlex, Jorma Mattila has authored 33 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 10 papers in Oncology and 9 papers in Surgery. Recurrent topics in Jorma Mattila's work include Cancer Genomics and Diagnostics (8 papers), Liver Disease Diagnosis and Treatment (7 papers) and Liver Diseases and Immunity (6 papers). Jorma Mattila is often cited by papers focused on Cancer Genomics and Diagnostics (8 papers), Liver Disease Diagnosis and Treatment (7 papers) and Liver Diseases and Immunity (6 papers). Jorma Mattila collaborates with scholars based in Finland, Estonia and Denmark. Jorma Mattila's co-authors include Olli Kallioniemi, Timo Koivula, Matti Lehtinen, K Lauslahti, T Hietanen, R. Punnonen, Guillermo Blanco, M. Alavaikko, Isto Nordback and Marja Hyöty and has published in prestigious journals such as Gastroenterology, PEDIATRICS and Cancer.

In The Last Decade

Jorma Mattila

32 papers receiving 1.2k citations

Peers

Jorma Mattila
Comparison fields: 5 of 69
  • Oncology 448
  • Cancer Research 362
  • Epidemiology 322
  • Surgery 258
  • Pulmonary and Respiratory Medicine 199
Judith Burnham United States
Michael Jeffers Ireland
Pietro Mingazzini Italy
Antonio Vetrani Italy
F. A. Beale Canada
Yoshiharu Ohaki Japan
S. Thomas Traweek United States
Michele De Nictolis Italy
Hirokazu Nishihira Japan
Gia‐Khanh Nguyen Canada
Judith Burnham United States View profile →
Citations per field, relative to Jorma Mattila
Jorma Mattila · 1×
Citations per year, relative to Jorma Mattila
Jorma Mattila · 1×

Countries citing papers authored by Jorma Mattila

Since Specialization
Citations

This map shows the geographic impact of Jorma Mattila's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorma Mattila with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorma Mattila more than expected).

Fields of papers citing papers by Jorma Mattila

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jorma Mattila. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorma Mattila. The network helps show where Jorma Mattila may publish in the future.

Co-authorship network of co-authors of Jorma Mattila

This figure shows the co-authorship network connecting the top 25 collaborators of Jorma Mattila. A scholar is included among the top collaborators of Jorma Mattila based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jorma Mattila. Jorma Mattila is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Proliferative and Anti-Apoptotic Activity of Esophageal Mucosa in Gastroesophageal Reflux Disease Is Not Affected by Fundoplication: A 4-Year Follow-Up Study European Surgical Research Tuomo Rantanen, Niku Oksala et al. 0
2 Erythrocyte concentrations of metabolites or cumulative doses of 6‐mercaptopurine and methotrexate do not predict liver changes in children treated for acute lymphoblastic leukemia Pediatric Blood & Cancer Päivi Halonen, Jorma Mattila et al. 10
3 Liver histology after current intensified therapy for childhood acute lymphoblastic leukemia: microvesicular fatty change and siderosis are the main findings Medical and Pediatric Oncology Päivi Halonen, Jorma Mattila et al. 21
4 Development of progressive pulmonary interstitial and intra‐alveolar cholesterol granulomas (PICG) associated with therapy‐resistant chronic systemic juvenile arthritis (CJA) Pediatric Pulmonology Rüdiger Schultz, Jorma Mattila et al. 27
5 Liver involvement in patients operated for ulcerative colitis, with special reference to the association of cholangitis with colorectal dysplasia and carcinoma International Journal of Colorectal Disease Jorma Mattila, P. Aitola et al. 17
6 Atypical bronchopulmonary carcinoids show a tendency toward increased apoptotic and proliferative activity Cancer Ylermi Soini, Jorma Mattila et al. 41
7 Antibodies to pyruvate dehydrogenase in primary biliary cirrhosis: correlation with histology Apmis Kai Kisand, Kalle Kisand et al. 17
8 Histological improvement of oesophagitis after Nissen fundoplication Annals of Medicine Markku Luostarinen, Jorma Mattila et al. 4
9 Expression and therapeutic response related to apolipoprotein E polymorphism in primary biliary cirrhosis Journal of Hepatology Matti Vuoristo, Martti Färkkilâ et al. 15
10 Flow cytometric analysis of tumor DNA profile related to response to treatment and survival in small-cell lung cancer Medical Oncology Vesa Kataja, Jorma Mattila et al. 8
11 Clinical assessment compared with cyst fluid analysis in the differential diagnosis of cystic lesions in the pancreas Surgery Juhani Sand, Marja Hyöty et al. 97
12 A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid Gastroenterology Matti Vuoristo, Anna–Liisa Karvonen et al. 82
13 Is "indeterminate colitis" Crohn's disease in the long-term follow-up? PubMed M Matikainen, Jorma Mattila et al. 22
14 Ultrastructural aspects of liver injury with special reference to small bile ducts in patients with ulcerative colitis Liver International Jorma Mattila, Reino Pitkänen et al. 5
15 Primary undifferentiated small cell carcinoma of the esophagus: Clinicopathological and flow cytometric evaluation of eight cases Journal of Surgical Oncology J Isolauri, Jorma Mattila et al. 40
16 Prognostic Assessment in Stage I Ovarian Cancer Using a Discriminant Analysis with Clinicopathological and DNA Flow Cytometric Data Gynecologic and Obstetric Investigation R. Punnonen, Olli Kallioniemi et al. 8
17 Primary invasive and in situ vaginal carcinoma. Flow cytometric analysis of DNA aneuploidy and cell proliferation from archival paraffin-embedded tissue European Journal of Obstetrics & Gynecology and Reproductive Biology R. Punnonen, Olli Kallioniemi et al. 5
18 Improving the prognostic value of DNA flow cytometry in breast cancer by combining DNA index and S-phase fraction: A proposed classification of DNA histograms in breast cancer Cancer Olli Kallioniemi, Guillermo Blanco et al. 199
19 DNA flow cytometric analysis indicates that many breast cancers detected in the first round of mammographic screening have a low malignant potential International Journal of Cancer Olli Kallioniemi, A Kärkkäinen et al. 20
20 Prognostic significance of dna index, multiploidy, and S-phase fraction in ovarian cancer Cancer Olli Kallioniemi, Timo Koivula et al. 179

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026